Efficacy of anti-influenza immunoglobulin (FLU-IGIV) in ferrets and mice infected with 2009 pandemic influenza virus.
In this study, we have tested the efficacy of a human plasma-derived IgG product (FLU-IGIV) against seasonal influenza in mouse and ferret models of influenza infection. FLU-IGIV successfully protected mice (100% survival) against lethal influenza infection. Also, the survival rate observed with FLU-IGIV treatment was better than the survival rate observed with oseltamivir (60% survival). FLU-IGIV significantly reduced the viral load in the lungs compared to placebo (PBS) in ferrets infected with influenza A/California/July 2009 (H1N1pdm09) virus. Overall, these studies demonstrate the efficacy of human plasma-derived FLU-IGIV in relevant animal models of influenza virus infection.
PMID: 32114033 [PubMed - as supplied by publisher]
Source: Antiviral Research - Category: Virology Authors: Qiu H, Andersen H, Tarbet EB, Muhammad FS, Carnelley T, Pronyk R, Barker D, Kodihalli S Tags: Antiviral Res Source Type: research
More News: Bird Flu | Bird Flu (H5N1 Avian Influenza) Vaccine | Flu Pandemic | Influenza | Influenza Vaccine | Oseltamivir | Pandemics | Study | Tamiflu | Vaccines | Veterinary Vaccinations | Virology